Ferring Grants
Grant Recipients
Click here to read more about the 2019 Grant Recipients!
- Katherine Burns – University of Cincinnati, College of Medicine
Targeting neutrophilic responses in the initiation of endometriosis.
- Charbonney Emmanuel – CHUM, University of Montreal
New insights in the role of uric acid in the pathogenesis of hepatic encephalopathy
- James Checco – University of Nebraska-Lincoln
A multi-analytical approach to identify interstitial cystitis/bladder pain syndrome (IC/BPS) biomarkers in urine
- Jennifer Condon – Wayne State University
Pharmacological targeting of GRP78 as a novel therapeutic for the inhibition of idiopathic preterm birth.
- Chen Huei Leo – Singapore University of Technology & Design
Relaxin treatment of liver fibrosis and vascular dysfunction using a novel animal model of non-alcoholic steatohepatitis
- Carlos Penha-Goncalves – Instituto Gulbenkian de Ciencia
Crosstalk of liver damage-associated endothelial cells and macrophages: exploiting TREM-2 as a therapeutic target in liver regenerative responses.
- Giorgio Ivan Russo – University of Catania
Association between protein expression and oncological outcomes in bladder cancer patients receiving radical cystectomy after BCG failure
- Xiaoqin Ye – University of Georgia
Intrauterine fluid resorption to facilitate embryo implantation
Click here to read more about the 2018 Grant Recipients!
- Fiona Cousins – Hudson Institute of Medical Research, Monash University
New treatment of endometriosis in a preclinical model.
- Laurent Derré – University Hospital of Lausanne (CHUV)
Immunotherapeutic strategies targeting ILC2 and MDSCs to treat bladder cancer.
- Marta Dueñas – Fundación para la Investigación Hospital 12 de Octubre
Evaluation of miRNAs and miRNA derived peptides (miPEPs) in liquid biopsies for bladder cancer diagnosis, prognosis and BCG treatment response.
- Tracey Edgell – Hudson Institute of Medical Research, Monash University
A novel non-hormonal therapeutic path for improving pregnancy success rates.
- Pradipta Ghosh – University of California, San Diego
Boolean Algorithms to Develop Precision Macrophage Reprogramming Therapeutics in IBD: From Math to (Wo)Man.
- Emmet Hirsch – NorthShore University HealthSystem
Surfactant Protein A (SP-A): A novel agent to prevent preterm birth.
- Harmeet Malhi – Mayo Clinic
Hepatocyte-derived extracellular vesicle sphingolipidomics are a diagnostic and prognostic biomarker in nonalcoholic steatohepatitis.
- Hiroshi Miyamoto – University of Rochester
The role of latrophilins in urothelial tumorigenesis: a novel chemopreventive target for bladder cancer.
Click here to read more about the 2017 Grant Recipients!
- Stéphane Bolduc – CHU de Québec – Université Laval Research Center
Identify protein(s) secreted by urothelial cell carcinoma (UCC) involved in modification of tumor-associated stroma by activation of Cancer-Associated Fibroblasts (CAF).
- Marcello Costa – Flinders University
Enteric neuropeptides modulation of colonic motility in health and disease.
- Warren Foster – McMaster University
Evaluation of a novel therapeutic intervention for the management of endometriosis in a mouse model
- Andrew Horne – University of Edinburgh
Targeting TGFβ-1 with an extracellular peptide inhibitor to treat women with peritoneal endometriosis.
- K. Joseph Hurt – University of Colorado
Adiponectin receptor regulation of myometrial contractility suggests novel therapeutic targets to augment uterine quiescence and prevent preterm birth.
- Ursula Kaiser – Brigham and Women’s Hospital, Harvard Medical School
Differential modulation of LH and FSH by GnRH analogs for improved treatment of reproductive disorders.
- Sarah Marshall – Monash University
Exploring novel therapies for preeclampsia: the role of soluble prorenin receptor on vasculature function.
- Kathryn Meier – Washington State University
FSH receptor as a therapeutic target in prostate cancer.
- Victor Navarro – Brigham and Women’s Hospital, Harvard Medical School
Targeting the Kappa Opioid Receptor to Regulate LH Pulses in PCOS Patients.
- Willis Samson – Saint Louis University, School of Medicine
A Novel Ligand (Adropin) – Receptor (GPR19) Handshake: Implications for the Control of Growth Hormone Secretion.
- John Taylor – Kansas University Medical Center
The Role of d-Dopachrome Tautomerase in Bladder Cancer Tumorigenesis.
- Suraj Unniappan – University of Saskatchewan
Nesfatin-1 and nesfatin-1-like peptide regulation of growth and stress hormones: novel targets for endocrine diseases.
- Henrique Veiga-Fernandes – Champalimaud Foundation
Neuro-immune interactions in inflammatory bowel diseases.
Click here to read more about the 2016 Grant Recipients!
- Stuart Brierley – Flinders University
Venom-derived NaV1.1 inhibitors as novel candidates for treating chronic visceral pain associated with irritable bowel syndrome (IBS.)
- James Deane – Hudson Institute of Medical Research
Investigating the requirement for Notch and Hedgehog signalling in the endometrial stem/progenitor populations that cause endometriosis.
- Laurent Derré – Centre Hospitalier Universitaire Vaudois
Understanding Siglec-related immunity in bladder cancer.
- Renjie Jin– Vanderbilt University
Sensitizing castration-resistant prostate cancer to anti-androgens by targeting gastrin-releasing peptide (GRP) receptor
- Florenta Kullmann – University of Pittsburgh
Artemin: a novel target for treatment of interstitial cystitis/bladder pain syndrome (IC/BPS)
- Mireille Lahoud – Monash University
The development of Clec12A-ligands as a therapeutic approach to regulate gastrointestinal inflammation
- Padma Murthi – Monash University
Investigating the role of novel peptide as an effective target to improve placental function in preeclampsia
- Markus Muttenthaler – University of Queensland
Mapping the location and function of oxytocin and vasopressin receptors throughout the gut
- Rodrigo Pacheco – Fundación Ciencia & Vida
Targeting heteromers formed by G-protein coupled receptors involved in the gut-homing of T-cells in inflammatory bowel diseases (IBD)
- Aritro Sen – University of Rochester Medical Center
Regulation of AMH expression by GDF9, BMP15 and FSH during follicular development as a novel therapeutic option
- Marie van Dijk – Academic Medical Center, University of Amsterdam
ELABELA as a potential biomarker and therapeutic for pre-eclampsia
- Steven Cohn – University of Virginia
Immunomodulation of RELMβ as a treatment for IBD
- Nardhy Gomez-Lopez – Wayne State University School of Medicine
A role for exendin-4 in the prevention of preterm birth
- Peter Gray – The Salk Institute for Biological Studies
Targeting Cripto in castration-resistant prostate cancer
- Guiying Nie– Hudson Institute of Medical Research
Improving fertility by targeting a novel uterine barrier for embryo
implantation
- Laura Parry – The University of Melbourne
Treatment of vascular dysfunction in preeclampsia
- Stuart Brierley – Flinders University
Venom-derived NaV1.1 inhibitors as novel candidates for treating chronic visceral pain associated with irritable bowel syndrome (IBS.)
- Kathleen M. Caron – University of North Carolina at Chapel Hill
Adrenomedullin delivery to improve reproductive outcomes
- Jakob Begun – Mater Research Institute
Towards an oral IL-22 agonist for ulcerative colitis